TransCon hGH, an investigational GHD therapy administered once weekly

Our investigational growth hormone prodrug releases somatropin (rhGH or hGH) with once-weekly administration. Marketing applications have been submitted in the United States and Europe for pediatric growth hormone deficiency (GHD).

We are passionate about patients and science

We are a dynamic place to grow and learn with a unique global culture and entrepreneurial spirit.

You are about to access www.ascendispharma.us, which includes information intended for U.S. residents only. Click below to confirm.

Are you a U.S. resident?

If so, please confirm below to proceed to our U.S. website. If not, continue to our global website.